Page last updated: 2024-08-18

thiophenes and Adenocarcinoma, Clear Cell

thiophenes has been researched along with Adenocarcinoma, Clear Cell in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Harada, T; Itamochi, H; Kato, M; Kigawa, J; Kudoh, A; Naniwa, J; Nishimura, M; Oishi, T; Oumi, N; Sato, S; Shimada, M	1
Ashworth, A; Dexter, T; El-Bahrawy, M; Faratian, D; Fenwick, K; Gabra, H; Gao, Q; Geyer, FC; Gore, ME; Graham, A; Jameson, C; Kaye, SB; Lambros, MB; Lord, CJ; Mackay, A; Marchiò, C; McCluggage, WG; Natrajan, R; Paige, AJ; Parry, S; Rayter, S; Reis-Filho, JS; Savage, K; Tamber, N; Tan, DS; Vatcheva, R; Williams, A; Zvelebil, M	1

Other Studies

2 other study(ies) available for thiophenes and Adenocarcinoma, Clear Cell

Article	Year
Checkpoint kinase inhibitor AZD7762 overcomes cisplatin resistance in clear cell carcinoma of the ovary. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2014, Volume: 24, Issue:1 Topics: Adenocarcinoma, Clear Cell; Animals; Antineoplastic Agents; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Drug Synergism; Female; Mice; Mice, Nude; Ovarian Neoplasms; Protein Kinase Inhibitors; Thiophenes; Urea; Xenograft Model Antitumor Assays	2014
PPM1D is a potential therapeutic target in ovarian clear cell carcinomas. Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, Apr-01, Volume: 15, Issue:7 Topics: Adenocarcinoma, Clear Cell; Cell Line, Tumor; Chromosome Aberrations; Chromosomes, Human, Pair 17; Comparative Genomic Hybridization; Cyclopentanes; Enzyme Inhibitors; Female; Gene Amplification; Gene Expression Profiling; Genes, p53; Humans; Mutation; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Phosphoprotein Phosphatases; Protein Phosphatase 2C; RNA Interference; Thiophenes	2009

Article

Year

Checkpoint kinase inhibitor AZD7762 overcomes cisplatin resistance in clear cell carcinoma of the ovary.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2014, Volume: 24, Issue:1

Topics: Adenocarcinoma, Clear Cell; Animals; Antineoplastic Agents; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Drug Synergism; Female; Mice; Mice, Nude; Ovarian Neoplasms; Protein Kinase Inhibitors; Thiophenes; Urea; Xenograft Model Antitumor Assays

2014

PPM1D is a potential therapeutic target in ovarian clear cell carcinomas.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, Apr-01, Volume: 15, Issue:7

Topics: Adenocarcinoma, Clear Cell; Cell Line, Tumor; Chromosome Aberrations; Chromosomes, Human, Pair 17; Comparative Genomic Hybridization; Cyclopentanes; Enzyme Inhibitors; Female; Gene Amplification; Gene Expression Profiling; Genes, p53; Humans; Mutation; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Phosphoprotein Phosphatases; Protein Phosphatase 2C; RNA Interference; Thiophenes

2009